HEADER NUCLEAR PROTEIN 17-APR-25 9UK3 TITLE CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH PEPTIDE AC-MRTEPRPPAP-NH2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SCRIB OVERLAPPING OPEN READING FRAME PROTEIN; COMPND 3 CHAIN: B; COMPND 4 SYNONYM: OSCRIB; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: WD REPEAT-CONTAINING PROTEIN 5; COMPND 8 CHAIN: A; COMPND 9 SYNONYM: BMP2-INDUCED 3-KB GENE PROTEIN; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 GENE: WDR5, BIG3; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS WD REPEAT, WIN SITE, MLL COMPLEX, NUCLEAR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.-R.MIN,M.ZHANG,M.-X.CHEN REVDAT 3 10-DEC-25 9UK3 1 JRNL REVDAT 2 05-NOV-25 9UK3 1 JRNL REVDAT 1 08-OCT-25 9UK3 0 JRNL AUTH M.ZHANG,M.CHEN,P.LI,J.MIN JRNL TITL THERAPEUTIC TARGETING OF WDR5-MLL1 BY EMBOW-DERIVED PEPTIDES JRNL TITL 2 SUPPRESSES LEUKEMIA PROGRESSION. JRNL REF CELL CHEM BIOL V. 32 1353 2025 JRNL REFN ESSN 2451-9456 JRNL PMID 41135522 JRNL DOI 10.1016/J.CHEMBIOL.2025.10.002 REMARK 2 REMARK 2 RESOLUTION. 1.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20.1_4487: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.930 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 31809 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1621 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 58.4800 - 3.8900 1.00 2692 160 0.1387 0.1646 REMARK 3 2 3.8600 - 3.0800 0.92 2355 138 0.1497 0.1673 REMARK 3 3 3.0800 - 2.6900 1.00 2534 143 0.1730 0.2018 REMARK 3 4 2.6900 - 2.4400 1.00 2560 126 0.1841 0.2329 REMARK 3 5 2.4400 - 2.2700 1.00 2520 125 0.1770 0.2312 REMARK 3 6 2.2700 - 2.1400 1.00 2523 132 0.1745 0.2193 REMARK 3 7 2.1400 - 2.0300 1.00 2521 144 0.1844 0.2109 REMARK 3 8 2.0300 - 1.9400 1.00 2486 144 0.1819 0.2245 REMARK 3 9 1.9400 - 1.8700 1.00 2490 143 0.1895 0.2410 REMARK 3 10 1.8700 - 1.8000 1.00 2516 108 0.2142 0.2375 REMARK 3 11 1.8000 - 1.7400 1.00 2511 127 0.2479 0.2944 REMARK 3 12 1.7400 - 1.6900 1.00 2480 131 0.2783 0.3440 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.070 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2521 REMARK 3 ANGLE : 0.981 3425 REMARK 3 CHIRALITY : 0.063 384 REMARK 3 PLANARITY : 0.007 429 REMARK 3 DIHEDRAL : 7.735 334 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9UK3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-APR-25. REMARK 100 THE DEPOSITION ID IS D_1300058619. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-24 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31858 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.690 REMARK 200 RESOLUTION RANGE LOW (A) : 58.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 9.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 5.5, 25% W/V REMARK 280 POLYETHYLENE GLYCOL 3,350, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.48600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 42.26950 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.48600 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 42.26950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 662 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA B 9 REMARK 465 PRO B 10 REMARK 465 NH2 B 11 REMARK 465 SER A 22 REMARK 465 ALA A 23 REMARK 465 THR A 24 REMARK 465 GLN A 25 REMARK 465 SER A 26 REMARK 465 LYS A 27 REMARK 465 PRO A 28 REMARK 465 THR A 29 REMARK 465 PRO A 30 REMARK 465 VAL A 31 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 32 CE NZ REMARK 470 TRP A 59 CZ3 REMARK 470 LYS A 67 NZ REMARK 470 LYS A 78 CG CD CE NZ REMARK 470 LYS A 126 CE NZ REMARK 470 LYS A 159 CG CD CE NZ REMARK 470 LYS A 162 CE NZ REMARK 470 ARG A 181 NE CZ NH1 NH2 REMARK 470 LYS A 227 CG CD CE NZ REMARK 470 LYS A 247 CG CD CE NZ REMARK 470 GLU A 292 CD OE1 OE2 REMARK 470 GLN A 298 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 234 45.14 -81.48 REMARK 500 LEU A 321 -167.01 -78.81 REMARK 500 ASP A 324 -62.71 -121.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 706 DISTANCE = 6.84 ANGSTROMS DBREF 9UK3 B 1 10 UNP C0HLS1 OSCRI_HUMAN 1 10 DBREF 9UK3 A 22 334 UNP P61964 WDR5_HUMAN 22 334 SEQADV 9UK3 ACE B 0 UNP C0HLS1 ACETYLATION SEQADV 9UK3 NH2 B 11 UNP C0HLS1 AMIDATION SEQRES 1 B 12 ACE MET ARG THR GLU PRO ARG PRO PRO ALA PRO NH2 SEQRES 1 A 313 SER ALA THR GLN SER LYS PRO THR PRO VAL LYS PRO ASN SEQRES 2 A 313 TYR ALA LEU LYS PHE THR LEU ALA GLY HIS THR LYS ALA SEQRES 3 A 313 VAL SER SER VAL LYS PHE SER PRO ASN GLY GLU TRP LEU SEQRES 4 A 313 ALA SER SER SER ALA ASP LYS LEU ILE LYS ILE TRP GLY SEQRES 5 A 313 ALA TYR ASP GLY LYS PHE GLU LYS THR ILE SER GLY HIS SEQRES 6 A 313 LYS LEU GLY ILE SER ASP VAL ALA TRP SER SER ASP SER SEQRES 7 A 313 ASN LEU LEU VAL SER ALA SER ASP ASP LYS THR LEU LYS SEQRES 8 A 313 ILE TRP ASP VAL SER SER GLY LYS CYS LEU LYS THR LEU SEQRES 9 A 313 LYS GLY HIS SER ASN TYR VAL PHE CYS CYS ASN PHE ASN SEQRES 10 A 313 PRO GLN SER ASN LEU ILE VAL SER GLY SER PHE ASP GLU SEQRES 11 A 313 SER VAL ARG ILE TRP ASP VAL LYS THR GLY LYS CYS LEU SEQRES 12 A 313 LYS THR LEU PRO ALA HIS SER ASP PRO VAL SER ALA VAL SEQRES 13 A 313 HIS PHE ASN ARG ASP GLY SER LEU ILE VAL SER SER SER SEQRES 14 A 313 TYR ASP GLY LEU CYS ARG ILE TRP ASP THR ALA SER GLY SEQRES 15 A 313 GLN CYS LEU LYS THR LEU ILE ASP ASP ASP ASN PRO PRO SEQRES 16 A 313 VAL SER PHE VAL LYS PHE SER PRO ASN GLY LYS TYR ILE SEQRES 17 A 313 LEU ALA ALA THR LEU ASP ASN THR LEU LYS LEU TRP ASP SEQRES 18 A 313 TYR SER LYS GLY LYS CYS LEU LYS THR TYR THR GLY HIS SEQRES 19 A 313 LYS ASN GLU LYS TYR CYS ILE PHE ALA ASN PHE SER VAL SEQRES 20 A 313 THR GLY GLY LYS TRP ILE VAL SER GLY SER GLU ASP ASN SEQRES 21 A 313 LEU VAL TYR ILE TRP ASN LEU GLN THR LYS GLU ILE VAL SEQRES 22 A 313 GLN LYS LEU GLN GLY HIS THR ASP VAL VAL ILE SER THR SEQRES 23 A 313 ALA CYS HIS PRO THR GLU ASN ILE ILE ALA SER ALA ALA SEQRES 24 A 313 LEU GLU ASN ASP LYS THR ILE LYS LEU TRP LYS SER ASP SEQRES 25 A 313 CYS HET ACE B 0 3 HETNAM ACE ACETYL GROUP FORMUL 1 ACE C2 H4 O FORMUL 3 HOH *325(H2 O) SHEET 1 AA1 4 ALA A 36 LEU A 41 0 SHEET 2 AA1 4 ILE A 327 LYS A 331 -1 O ILE A 327 N LEU A 41 SHEET 3 AA1 4 ILE A 315 ALA A 320 -1 N SER A 318 O LYS A 328 SHEET 4 AA1 4 VAL A 304 CYS A 309 -1 N ALA A 308 O ALA A 317 SHEET 1 AA2 4 VAL A 48 PHE A 53 0 SHEET 2 AA2 4 TRP A 59 SER A 64 -1 O SER A 63 N SER A 49 SHEET 3 AA2 4 LEU A 68 GLY A 73 -1 O TRP A 72 N LEU A 60 SHEET 4 AA2 4 PHE A 79 SER A 84 -1 O ILE A 83 N ILE A 69 SHEET 1 AA3 4 ILE A 90 TRP A 95 0 SHEET 2 AA3 4 LEU A 101 SER A 106 -1 O ALA A 105 N SER A 91 SHEET 3 AA3 4 THR A 110 ASP A 115 -1 O TRP A 114 N LEU A 102 SHEET 4 AA3 4 CYS A 121 LYS A 126 -1 O LEU A 125 N LEU A 111 SHEET 1 AA4 4 VAL A 132 PHE A 137 0 SHEET 2 AA4 4 LEU A 143 SER A 148 -1 O GLY A 147 N PHE A 133 SHEET 3 AA4 4 VAL A 153 ASP A 157 -1 O TRP A 156 N ILE A 144 SHEET 4 AA4 4 CYS A 163 LEU A 167 -1 O LEU A 167 N VAL A 153 SHEET 1 AA5 4 VAL A 174 PHE A 179 0 SHEET 2 AA5 4 LEU A 185 SER A 190 -1 O VAL A 187 N HIS A 178 SHEET 3 AA5 4 LEU A 194 ASP A 199 -1 O TRP A 198 N ILE A 186 SHEET 4 AA5 4 CYS A 205 ILE A 210 -1 O LEU A 206 N ILE A 197 SHEET 1 AA6 4 VAL A 217 PHE A 222 0 SHEET 2 AA6 4 TYR A 228 THR A 233 -1 O LEU A 230 N LYS A 221 SHEET 3 AA6 4 THR A 237 ASP A 242 -1 O TRP A 241 N ILE A 229 SHEET 4 AA6 4 LYS A 247 TYR A 252 -1 O LYS A 247 N ASP A 242 SHEET 1 AA7 4 ALA A 264 SER A 267 0 SHEET 2 AA7 4 TRP A 273 SER A 276 -1 O VAL A 275 N ASN A 265 SHEET 3 AA7 4 VAL A 283 ASN A 287 -1 O TYR A 284 N SER A 276 SHEET 4 AA7 4 ILE A 293 LEU A 297 -1 O LEU A 297 N VAL A 283 LINK C ACE B 0 N MET B 1 1555 1555 1.32 CRYST1 41.072 80.972 84.539 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024347 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012350 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011829 0.00000 CONECT 1 2 3 4 CONECT 2 1 CONECT 3 1 CONECT 4 1 MASTER 283 0 1 0 28 0 0 6 2710 2 4 26 END